Pathfinders in Biopharma
Podcast autorstwa RBC Capital Markets
46 Odcinki
-
Uncertainty reigns, but opportunity persists for biotech’s 2025
Opublikowany: 7.02.2025 -
Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments
Opublikowany: 22.11.2024 -
Former Investor Who Chose Broadcasting Over Biotech ETFs
Opublikowany: 30.09.2024 -
Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?
Opublikowany: 29.08.2024 -
Shots-on-Goal Licensing Company Aims for Breakthroughs
Opublikowany: 19.07.2024 -
Why Biopharma Needs to Tell Better Stories on Novel Drugs
Opublikowany: 11.07.2024 -
Venture capital velocity: What’s driving renewed momentum in biotech?
Opublikowany: 8.07.2024 -
Pharma Understands Phase One Data – But Does the Market?
Opublikowany: 21.06.2024 -
Davern Capital sees GLP-1 Opportunities Beyond Obesity
Opublikowany: 14.06.2024 -
Betting on Healthcare’s Future Hits – and Misses
Opublikowany: 10.06.2024 -
Innovation and an Aging Population Drive MedTech
Opublikowany: 5.06.2024 -
Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing
Opublikowany: 3.06.2024 -
Biotech with a Mission to Target Unmet Cancer Needs
Opublikowany: 31.05.2024 -
The M&A Pool Set to Accelerate Biotech Innovation
Opublikowany: 3.04.2024 -
How PIPEs finally unblocked biotech’s funding flows
Opublikowany: 29.03.2024 -
Disruptive Forces in Healthcare: Why HCIT is finally set to bounce back
Opublikowany: 7.03.2024 -
Will the Biotech Rebound Run into Pricing Policy Obstacles?
Opublikowany: 27.02.2024 -
Few IPOs but plenty of follow-on for biotech in 2023
Opublikowany: 22.01.2024 -
U.S. Outlook: Will the US economy achieve a soft landing in 2024?
Opublikowany: 29.12.2023 -
Raising Venture Capital: A New Playbook for A New Era in Biotech
Opublikowany: 22.11.2023
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
